Related Experiment Videos

A Japanese family with high density lipoprotein deficiency

Atherosclerosis
|October 1, 1983
PubMed

Insights

This study identifies two siblings with familial high density lipoprotein (HDL) deficiency, a rare genetic disorder. Their condition presented with extremely low HDL cholesterol and specific apolipoprotein levels, consistent with Tangier disease.

Area of Science:

  • Lipid Metabolism
  • Genetics
  • Biochemistry

Background:

  • Familial high density lipoprotein (HDL) deficiency is a rare genetic disorder characterized by severely reduced levels of HDL cholesterol in the plasma.
  • Understanding the genetic basis and clinical manifestations of HDL deficiency is crucial for diagnosing and managing related metabolic abnormalities.

Observation:

  • Two siblings from a Japanese family presented with markedly reduced plasma HDL (0-1 mg/dl) and very low total cholesterol (30-60 mg/dl).
  • Plasma concentrations of apolipoprotein (Apo) A-I and Apo A-II were significantly decreased in the affected siblings.
  • Electron microscopy revealed two distinct lipoprotein particle populations in the HDL fraction, and liver biopsy showed lipid deposition in reticuloendothelial cells.

Findings:

  • The clinical and biochemical findings in the affected siblings were consistent with homozygous familial HDL deficiency, also known as Tangier disease.
  • Parents and some offspring exhibited lower HDL cholesterol levels, suggesting a heterozygote state, though Apo A-I and Apo A-II levels were normal in heterozygotes.
  • Plasma low density lipoprotein (LDL) exhibited altered electrophoretic mobility in both patients and heterozygotes compared to normal subjects.

Implications:

  • This case highlights the genetic heterogeneity and phenotypic variability within families affected by HDL deficiency.
  • Further research into the specific genetic mutations and their impact on lipoprotein metabolism is warranted.
  • Understanding these lipid abnormalities may offer insights into cardiovascular disease risk stratification and potential therapeutic targets.

Related Concept Videos